Researcher Profiles

写真a

TANI YOKO

Organization

Graduate School of Medicine Department of Clinical Medical Science Lecturer
School of Medicine Department of Medical Science

Affiliation

Institute of Medcine

Affiliation campus

Abeno Campus

Position

Graduate School of Medicine Department of Clinical Medical Science

Lecturer 2024.10 - Now
School of Medicine Department of Medical Science

Lecturer 2024.10 - Now

Degree

博士（医学）（ Osaka Metropolitan University ）

Research Areas

Life Science / Tumor diagnostics and therapeutics / 胸部悪性腫瘍

Papers

Efficacy of ramucirumab combined with erlotinib or osimertinib in untreated EGFR-mutated NSCLC patients with asymptomatic brain metastases: insights from molecular biomarkers in the RELAY-brain trial

Kaneda H.

Investigational New Drugs 43 ( 1 ) 147 - 156 2025.02（ ISSN:01676997 ）

　More details

DOI： 10.1007/s10637-025-01505-y

PubMed
Establishing a new human lung squamous cell carcinoma cell line, OMUL-1, expressing insulin-like growth factor 1 receptor and programmed cell death ligand 1

Nagamine H.

Thoracic Cancer 16 ( 1 ) e15488 2025.01（ ISSN:17597706 ）

　More details

DOI： 10.1111/1759-7714.15488

PubMed
Differences in Lung Cancer-related Clinical Practice and Basic Research Background between Japan and China: A Narrative Review

Wang Lan, Miao Yiyan, Gu Yihang, Kawaguchi Tomoya, Mizutani Megumi, Nakai Toshiyuki, Watanabe Tetsuya, Asai Kazuhisa, Zhang Hui, Cai Wenwen, Tani Yoko, Kaneda Hiroyasu

Internal Medicine advpub ( 0 ) 2025（ ISSN:09182918 ）（ eISSN:13497235 ）

　More details

<p>With its increasing incidence, lung cancer has become one of the leading causes of cancer-related deaths worldwide, posing a great threat to the health and lives of patients. Due to varying economic and cultural backgrounds, there are significant differences in clinical treatment practices and related basic research on lung cancer between China and Japan. These differences are mainly reflected in many aspects, such as cancer prevention, cancer treatment, provision of medical insurance, patient compliance, medical education system, and sources of research funding. By understanding these differences, China and Japan can learn from each other, make progress together, and strengthen further exchanges and cooperation, which will help improve the long-term efficacy of lung cancer treatment and improve patients' clinical outcomes. </p>

DOI： 10.2169/internalmedicine.4808-24

PubMed
Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer

Sugimoto A.

Scientific Reports 14 ( 1 ) 19596 2024.12

　More details

DOI： 10.1038/s41598-024-70214-y

PubMed
Application and Advancement of Bronchoscopic Biopsy Techniques for the Diagnosis of Pulmonary Nodules

Wang Lan, Miao Yiyan, Kaneda Hiroyasu, Kawaguchi Tomoya, Sheng Yifan, Gu Yihang, Mizutani Megumi, Watanabe Tetsuya, Asai Kazuhisa, Zhang Hui, Tani Yoko, Nakai Toshiyuki

Respiratory Endoscopy 2 ( 3 ) 122 - 127 2024.11（ eISSN:27583813 ）

　More details

<p>With the popularization of low-dose computed tomography scanning technology, the detection rate of pulmonary nodules has significantly increased, and the diagnosis of pulmonary nodules has become a critical issue in the medical field. Close monitoring and early detection of potentially malignant nodules are essential for improving patient survival. Bronchoscopic biopsy has shown remarkable results for the histological diagnosis of pulmonary nodules. Advances in this field have led to several innovative diagnostic tools, including endobronchial ultrasound, ultrathin bronchoscopy, virtual bronchoscopic navigation, electromagnetic navigation bronchoscopy, and robotic-assisted bronchoscopy. The development of these techniques has greatly improved the diagnostic capabilities of bronchoscopy, especially for peripheral pulmonary nodules, thereby providing more effective diagnostic tools. We reviewed recent advances in interventional bronchoscopy for diagnosing and treating pulmonary nodules, with a particular focus on strategies for detecting peripheral pulmonary nodules.</p>

DOI： 10.58585/respend.2024-0039
Insulin-like growth factor 1 receptor expression correlates with programmed death ligand 1 expression and poor survival in non-small cell lung cancer

Nagamine H.

PLoS ONE 19 ( 10 October ) e0297397 2024.10

　More details

DOI： 10.1371/journal.pone.0297397

PubMed
Lack of Association Between Immunotherapy and Improvement of Survival for Non-small Cell Lung Cancer Patients With Hemodialysis: A Nationwide Retrospective Cohort Study

Sawa K.

Clinical Lung Cancer 25 ( 2 ) 144 - 150.e3 2024.03（ ISSN:15257304 ）

　More details

DOI： 10.1016/j.cllc.2023.11.003

PubMed
Acute myeloid leukemia post‑cytotoxic therapy following chemotherapy for thymoma: A case report.

Manabe M, Tani Y, Inano N, Hagiwara Y, Sogabe N, Nanno S, Koh KR

Medicine international 4 ( 1 ) 9 2024.01（ ISSN:2754-3242 ）

　More details

DOI： 10.3892/mi.2024.133

PubMed

▼display all

MISC

Application and Advancement of Bronchoscopic Biopsy Techniques for the Diagnosis of Pulmonary Nodules(タイトル和訳中)

Wang Lan, Miao Yiyan, Kaneda Hiroyasu, Kawaguchi Tomoya, Sheng Yifan, Gu Yihang, Mizutani Megumi, Watanabe Tetsuya, Asai Kazuhisa, Zhang Hui, Tani Yoko, Nakai Toshiyuki

Respiratory Endoscopy 2 ( 3 ) 122 - 127 2024.11

Presentations

進行性非小細胞肺がんの日本人患者におけるcemiplimab単独投与と化学療法併用(Cemiplimab Alone or with Chemotherapy in Japanese Patients with Advanced Non-Small Cell Lung Cancer)

Sato Yuki, Tani Yoko, Ishii Hidenobu, Katakura Seigo, Oki Masahide, Watanabe Yasutaka, Yokoyama Toshihide, Naoki Katsuhiko, Pouliot Jean-Francois, Paccaly Anne, Kim Eric, Mani Jayakumar, Li Siyu, Lowy Israel, Seebach Frank, Mathias Melissa, Ikeda Satoshi

肺癌 2024.10 (NPO)日本肺癌学会
糖尿病合併症例における化学放射線療法後の肺臓炎重症化リスクに関する検討

阪上茉衣, 井口治男, 椋本宜学, 谷陽子, 金田裕靖, 川口知哉, 澁谷景子

肺癌 2024.10 (NPO)日本肺癌学会

Charge of on-campus class subject

呼吸器病学14 　肺癌、縦隔腫瘍、胸膜中皮腫①

2024 Undergraduate